FMO3 and hypertensive disorder: There is also limited data on FMO3 polymorphisms and its effect on hypertension, but studies provide conflicting results (Akerman et al., 1999; Cashman et al., 2000; Cashman et al., 2003; Dolan et al., 2005; D'Angelo et al., 2013).